Unigroup Guoxin Microelectronics Co Ltd

Unigroup Guoxin released its 2026 interim report, with net profit attributable to the parent company of 798 million yuan, up 15.29% from the same period last year. Total operating revenue was 3.443 billion yuan, up 13.00% year on year, marking a second consecutive year of growth. Net cash inflow from operating activities was 827 million yuan, up 73.14% year on year. The company's latest asset-liability ratio was 25.64%, gross margin was 53.59%, return on equity was 5.57%, and diluted earnings per share was 0.95 yuan.

Unigroup Guoxin released its 2026 half-year report, achieving operating revenue of 3.443 billion yuan, up 13% year on year, and net profit attributable to shareholders of the listed company of 798 million yuan, up 15.29% year on year. In the first half, driven by continued investment in artificial intelligence infrastructure, high-performance computing and advanced storage technology, the industry maintained an explosive expansion trend. By product category, the memory segment led performance with a sharp year-on-year increase of 305%; logic chips grew 45%; and all other product categories also achieved positive year-on-year growth. The company's second-quarter net profit was 463 million yuan, and first-quarter net profit was 334 million yuan, meaning second-quarter net profit rose 38% quarter on quarter.

On the evening of July 9, multiple A-share listed companies issued announcements on share buybacks and stake increases. Neusoft announced that, because its stock price is below net asset value per share, it plans to buy back shares worth 100 million to 200 million yuan and cancel them all. Based on a maximum buyback price of 11.67 yuan per share, the number of shares to be repurchased is approximately 8.57 million to 17.14 million, accounting for 0.72% to 1.43% of total share capital. Yibai Pharmaceutical will cancel 7.53 million repurchased shares, representing 0.95% of total share capital, after which total share capital will change to 784 million shares. Unigroup Guoxin will cancel 6.40 million shares because the repurchased shares were not used for an incentive plan within 36 months. Sansure Biotech will cancel 4.45 million shares to reduce registered capital, aiming to boost earnings per share. Chongqing Pharmaceutical has completed the cancellation procedures for 15.41 million repurchased shares. Dazhong Mining made its first buyback of 580,000 shares, with a transaction amount of 17.51 million yuan. Jiayi Holdings made its first buyback of 64,200 shares, with a transaction amount of 1.99 million yuan. Qingmu Technology plans to buy back shares worth 20 million to 30 million yuan for incentive purposes. On the stake increase side, Sheng Jianhua, one of the actual controllers of Xidian New Energy, increased his stake by 614,900 shares, with an amount of 19.45 million yuan. Actual controllers Sheng Jianhua and Pan Shuxin plan to increase their combined stake by 10 million to 20 million yuan. The controlling shareholder of Shenghang Shipping, Wanda Holding Group, plans to increase its stake by no more than 6.10 million shares, with an amount of 66 million to 96 million yuan. Liu Xiaodong, the actual controller of Bairun Holdings, increased his stake by 1.12 million shares, with an amount of 17.98 million yuan, and plans to continue increasing his stake by 50 million to 100 million yuan. Some directors and senior executives of Longxi Bearing increased their combined stake by 67,400 shares, with an amount of 909,400 yuan.